Gene Symbol | UNC5B |
Entrez ID | 219699 |
Uniprot ID | Q8IZJ1 |
Description | unc-5 netrin receptor B |
Chromosomal Location | chr10: 71,212,570-71,302,864 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IEA |
BP |
GO:0006915 |
apoptotic process |
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
IEA |
BP |
GO:0007165 |
signal transduction |
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
IEA |
BP |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
IMP |
BP |
GO:0033564 |
anterior/posterior axon guidance |
The process in which the migration of an axon growth cone is directed to a specific target site along the anterior-posterior body axis in response to a combination of attractive and repulsive cues. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism. |
IEA |
BP |
GO:0043524 |
negative regulation of neuron apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
IMP |
BP |
GO:2001240 |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
IMP |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IEA |
CC |
GO:0016021 |
integral component of membrane |
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
IEA |
CC |
GO:0045121 |
membrane raft |
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
Domain ID | Description |
---|---|
IPR000488 |
Death domain |
IPR000884 |
Thrombospondin type-1 (TSP1) repeat |
IPR000906 |
ZU5 domain |
IPR003598 |
Immunoglobulin subtype 2 |
IPR003599 |
Immunoglobulin subtype |
IPR007110 |
Immunoglobulin-like domain |
IPR011029 |
Death-like domain |
IPR013098 |
Immunoglobulin I-set |
IPR013783 |
Immunoglobulin-like fold |
IPR033772 |
UPA domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04360 |
Axon guidance |
KEGG |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
SH3RF1 |
57630 |
Q7Z6J0 |
0.63 |
KIAA1524 |
57650 |
Q8TCG1 |
0.63 |
PPP2R1B |
5519 |
P30154 |
0.72 |
NTN1 |
9423 |
O95631 |
0.73 |
TMEM216 |
51259 |
Q9P0N5 |
0.49 |
TMEM17 |
200728 |
Q86X19 |
0.49 |
DAP |
1611 |
P51397 |
0.63 |
NEO1 |
4756 |
Q92859 |
0.63 |
NTRK1 |
4914 |
P04629 |
0.63 |
PPP2CA |
5515 |
P67775 |
0.63 |
TUBG1 |
7283 |
P23258 |
0.63 |
DAPK1 |
1612 |
P53355 |
0.89 |